Your TSH Is Normal, But You Feel Hypothyroid. Here's Why.

DIO2 is the enzyme responsible for converting inactive T4 hormone into active T3 hormone. It works in your liver, your brain, and your muscle tissue, so the conversion happens exactly where you need the energy and the clarity. When DIO2 is functioning normally, this conversion is efficient and seamless.

The Thr92Ala variant in DIO2 (rs225014) reduces the enzyme’s conversion efficiency. Roughly 12 to 15% of people carry the Ala/Ala genotype, the variant most associated with impaired conversion. People with this variant have normal TSH and T4 levels but tissue-level hypothyroidism because their cells cannot access the active T3 they need. You can take thyroid medication, your labs look perfect, and you still feel exhausted because the conversion step is broken at the genetic level.

You might experience this as persistent fatigue that doesn’t respond to thyroid replacement alone, cold intolerance, sluggish metabolism, difficulty losing weight, and sometimes depression or brain fog. You might feel significantly better on T3 supplementation or a combination T4/T3 medication, even though your doctor was initially reluctant to try it because your TSH looked normal.

Vitamin D doesn’t work unless your cells can receive it. VDR (Vitamin D Receptor) is the lock that allows your cells to open and let Vitamin D in. Without a functioning VDR, you can take massive doses of Vitamin D and remain functionally deficient because your cells cannot access what you’re supplementing.

VDR variants (BsmI, FokI, TaqI) are carried by roughly 30 to 50% of the population, depending on ancestry. These variants reduce how efficiently your cells bind and activate Vitamin D signaling, meaning your cells receive less functional Vitamin D even when your blood levels look adequate. This is particularly relevant for thyroid conversion because Vitamin D regulates the immune response against your own thyroid and is required for optimal thyroid hormone metabolism.

You might feel this as persistent Vitamin D deficiency symptoms despite supplementation, increased susceptibility to infection, bone weakness, or an worsening of thyroid antibodies even though your blood Vitamin D level appears normal. Your immune system may remain overactive against your thyroid tissue, perpetuating the conversion problem.

MTHFR catalyzes a critical step in converting dietary folate into the methylfolate your cells need. Methylfolate is required for methylation, the process that regulates gene expression throughout your body, including the genes that control thyroid antibody levels and thyroid hormone metabolism. When MTHFR is broken, your methylation cycle stalls, even if you’re eating plenty of B vitamins.

The C677T variant in MTHFR (rs1314549) is carried by roughly 40% of people of European ancestry. This variant reduces MTHFR enzyme activity by 35 to 40%, meaning your cells convert dietary folate to active methylfolate at only a fraction of the normal rate. The result is functional B vitamin deficiency at the cellular level, even when your diet is perfect and your bloodwork shows normal folate.

You might experience this as persistent fatigue despite adequate sleep, high homocysteine even on supplementation, worsening thyroid antibodies or thyroid symptoms despite medication, poor memory or concentration, or emotional sensitivity. Your thyroid conversion machinery depends on methylation working correctly, and if MTHFR is broken, conversion will suffer.

GC, also called VDBP (Vitamin D Binding Protein), is responsible for transporting Vitamin D through your bloodstream and delivering it to your tissues. The majority of Vitamin D in your blood is bound to GC; only a small fraction is “free” and bioavailable to your cells. GC variants determine how much Vitamin D is bound versus free, directly affecting how much Vitamin D your tissues can actually use.

GC variants (haplotypes 1s, 1f, 2) are common across all populations, with roughly 30 to 50% of people carrying variants that affect Vitamin D transport. Certain GC haplotypes increase the amount of Vitamin D that stays bound and unavailable to your tissues, meaning less free Vitamin D reaches the cells that convert thyroid hormone. This compounds if you also carry VDR variants; your Vitamin D is both poorly transported and poorly received.

You might experience this as poor response to Vitamin D supplementation, persistent Vitamin D deficiency symptoms despite adequate supplementation and sun exposure, or worsening thyroid function and fatigue even when your total Vitamin D blood level appears sufficient. Your thyroid conversion process is starved of the Vitamin D it requires.

BCMO1 converts beta-carotene from plant foods into retinol, the active form of Vitamin A your body uses. Vitamin A is essential for immune regulation, thyroid hormone receptor expression, and cellular health. If BCMO1 doesn’t work, you can eat plenty of orange and green vegetables and still be Vitamin A deficient because your body cannot convert what you’re eating into the active form.

The BCMO1 variants (R267S, A379V) are carried by roughly 45% of the population. People with these variants have significantly reduced conversion efficiency, meaning they extract only a fraction of the Vitamin A from plant foods and often develop functional Vitamin A deficiency despite adequate dietary intake. This is particularly important for thyroid health because Vitamin A regulates the immune system’s behavior toward your thyroid and is required for optimal thyroid hormone signaling.

You might experience this as poor immune tolerance toward your own thyroid, persistent or worsening thyroid antibodies even on supplementation, dry skin or eyes, poor night vision, or infections that don’t resolve quickly. Your immune system may remain overactive against thyroid tissue because it’s not receiving the Vitamin A signaling it needs.

HFE regulates hepcidin, the hormone that controls how much iron your intestines absorb and how much iron your cells retain. Iron is a critical cofactor for thyroid peroxidase and other enzymes involved in thyroid hormone production and metabolism. When HFE is broken, iron absorption becomes dysregulated, causing either iron overload or iron deficiency depending on the variant.

The HFE H63D variant (rs1799945) is carried by roughly 15 to 20% of people of European ancestry. This variant is associated with mild iron dysregulation, typically resulting in reduced iron absorption and a tendency toward functional iron deficiency even when dietary intake appears adequate. Iron deficiency impairs the enzymes required for T4-to-T3 conversion and thyroid hormone metabolism, creating a bottleneck in your conversion machinery.

You might experience this as persistent fatigue despite thyroid medication, poor thyroid response even with adequate supplementation, low ferritin levels (below 30-40 ng/mL), cold intolerance, or brittle nails and hair loss. Your conversion enzymes are starved for the iron they require to function.